These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32779526)

  • 21. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
    Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study.
    Zhang X; Zou H; Chen Y; Zhang H; Tian R; Meng J; Zhu Y; Guo H; Dai E; Zhu B; Liu Z; Jin Y; Li Y; Feng L; Zhuang H; Pan CQ; Li J; Duan Z
    BMC Med; 2021 Jul; 19(1):148. PubMed ID: 34253217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
    PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions.
    Hung WL; Wu JF; Ni YH; Chen HL; Chiang CL; Chang MH; Hsu HY
    Liver Int; 2019 Jun; 39(6):1052-1061. PubMed ID: 30790411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
    Euler GL; Copeland JR; Rangel MC; Williams WW
    Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen.
    Huang H; Ning M; Liu J; Chen J; Feng J; Dai Y; Hu Y; Zhou YH
    Hum Vaccin Immunother; 2019; 15(9):2183-2186. PubMed ID: 30735449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
    Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
    Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10μg recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
    Zhu FC; Sun KX; Pan HX; Yang ZH; Lu Y; Liang ZL; Liang XF; Wang FZ; Zeng Y; Li J
    Vaccine; 2016 May; 34(24):2656-62. PubMed ID: 27113166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].
    Wang FZ; Zheng H; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):457-461. PubMed ID: 28468062
    [No Abstract]   [Full Text] [Related]  

  • 39. Vertically acquired occult hepatitis B virus infection may become overt after several years.
    Eilard A; Andersson M; Ringlander J; Wejstål R; Norkrans G; Lindh M
    J Infect; 2019 Mar; 78(3):226-231. PubMed ID: 30658081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Rodríguez Lay LLA; Bello Corredor M; Montalvo Villalba MC; Chibás Ojeda AG; Sariego Frómeta S; Diaz González M; Abad Lamoth Y; Sánchez Wong M; Sausy A; Muller CP; Hübschen JM
    Arch Virol; 2017 Aug; 162(8):2393-2396. PubMed ID: 28439708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.